PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.39%
Positive revenue growth while 3088.T is negative. John Neff might see a notable competitive edge here.
9.46%
Positive gross profit growth while 3088.T is negative. John Neff would see a clear operational edge over the competitor.
9.87%
Positive EBIT growth while 3088.T is negative. John Neff might see a substantial edge in operational management.
9.85%
Positive operating income growth while 3088.T is negative. John Neff might view this as a competitive edge in operations.
20.61%
Net income growth 1.25-1.5x 3088.T's 14.61%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
20.62%
EPS growth 1.25-1.5x 3088.T's 14.58%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
20.62%
Diluted EPS growth 1.25-1.5x 3088.T's 14.58%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-0.00%
Share reduction while 3088.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.10%
10Y revenue/share CAGR above 1.5x 3088.T's 16.32%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
57.10%
5Y revenue/share CAGR above 1.5x 3088.T's 16.32%. David Dodd would look for consistent product or market expansions fueling outperformance.
57.10%
3Y revenue/share CAGR above 1.5x 3088.T's 16.32%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.35%
Net income/share CAGR above 1.5x 3088.T's 45.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
75.35%
5Y net income/share CAGR above 1.5x 3088.T's 45.52%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
75.35%
3Y net income/share CAGR above 1.5x 3088.T's 45.52%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
81.97%
10Y equity/share CAGR above 1.5x 3088.T's 19.30%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
81.97%
5Y equity/share CAGR above 1.5x 3088.T's 19.30%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
81.97%
3Y equity/share CAGR above 1.5x 3088.T's 19.30%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-26.67%
Cut dividends over 10 years while 3088.T stands at 15943.73%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-26.67%
Negative 5Y dividend/share CAGR while 3088.T stands at 15943.73%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-26.67%
Negative near-term dividend growth while 3088.T invests at 15943.73%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
4.39%
We show growth while 3088.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
13.38%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.97%
BV/share growth above 1.5x 3088.T's 3.02%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
51.23%
Debt growth far above 3088.T's 11.81%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.